JP2006504621A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504621A5
JP2006504621A5 JP2003576443A JP2003576443A JP2006504621A5 JP 2006504621 A5 JP2006504621 A5 JP 2006504621A5 JP 2003576443 A JP2003576443 A JP 2003576443A JP 2003576443 A JP2003576443 A JP 2003576443A JP 2006504621 A5 JP2006504621 A5 JP 2006504621A5
Authority
JP
Japan
Prior art keywords
compound
group
hiv
alkylene
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003576443A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504621A (ja
JP4808380B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/007032 external-priority patent/WO2003078438A1/en
Publication of JP2006504621A publication Critical patent/JP2006504621A/ja
Publication of JP2006504621A5 publication Critical patent/JP2006504621A5/ja
Application granted granted Critical
Publication of JP4808380B2 publication Critical patent/JP4808380B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003576443A 2002-03-12 2003-03-07 Hivプロテアーゼ阻害剤としてのカルバミン酸エステル Expired - Fee Related JP4808380B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36362802P 2002-03-12 2002-03-12
US60/363,628 2002-03-12
US43362702P 2002-12-13 2002-12-13
US60/433,627 2002-12-13
PCT/US2003/007032 WO2003078438A1 (en) 2002-03-12 2003-03-07 Carbamates as hiv protease inhibitors

Publications (3)

Publication Number Publication Date
JP2006504621A JP2006504621A (ja) 2006-02-09
JP2006504621A5 true JP2006504621A5 (cg-RX-API-DMAC10.html) 2006-04-13
JP4808380B2 JP4808380B2 (ja) 2011-11-02

Family

ID=28045322

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003576443A Expired - Fee Related JP4808380B2 (ja) 2002-03-12 2003-03-07 Hivプロテアーゼ阻害剤としてのカルバミン酸エステル

Country Status (7)

Country Link
US (2) US7157489B2 (cg-RX-API-DMAC10.html)
EP (1) EP1485387A1 (cg-RX-API-DMAC10.html)
JP (1) JP4808380B2 (cg-RX-API-DMAC10.html)
AU (1) AU2003213776A1 (cg-RX-API-DMAC10.html)
CA (1) CA2478731C (cg-RX-API-DMAC10.html)
MX (1) MXPA04008858A (cg-RX-API-DMAC10.html)
WO (1) WO2003078438A1 (cg-RX-API-DMAC10.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109230B2 (en) * 2002-01-07 2006-09-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
US20050131042A1 (en) * 2003-12-11 2005-06-16 Flentge Charles A. HIV protease inhibiting compounds
US8193227B2 (en) * 2003-12-11 2012-06-05 Abbott Laboratories HIV protease inhibiting compounds
WO2005087728A1 (en) 2004-03-11 2005-09-22 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
AU2005244121B2 (en) * 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
ES2331257T3 (es) 2005-02-25 2009-12-28 Tibotec Pharmaceuticals Sintesis de precursores de inhibidores de proteasas.
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
TWI385173B (zh) * 2005-11-28 2013-02-11 Tibotec Pharm Ltd 作為hiv蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物
TWI432438B (zh) * 2005-11-28 2014-04-01 Tibotec Pharm Ltd 作為hiv蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物及衍生物
CN104710330A (zh) * 2006-05-30 2015-06-17 泰博特克药品有限公司 作为hiv天冬氨酰基蛋白酶抑制剂的赖氨酸相关衍生物
PT2069303E (pt) 2006-07-21 2016-06-08 Gilead Sciences Inc Inibidores de protease antiviral
JP2009544708A (ja) * 2006-07-24 2009-12-17 ギリアード サイエンシーズ, インコーポレイテッド ビスフラニルプロテアーゼ阻害剤
WO2008133734A2 (en) * 2006-11-21 2008-11-06 Purdue Research Foundation Method and compositions for treating hiv infections
CN101636448B (zh) * 2006-12-15 2012-08-08 住化化科股份有限公司 烯烃系共聚物的水性乳状液
GB2452952A (en) * 2007-09-20 2009-03-25 Npil Pharmaceuticals N-[2-Hydroxy-3-(hydroxycarbonylamino)-3-methyl]-N-methyl-sulphonamide derivatives via N-[2-oxo-3-(hydroxycarbonylamino)-3-methyl]-N-methyl-imine skeleton
WO2009037416A1 (en) * 2007-09-20 2009-03-26 Npil Pharmaceuticals (Uk) Limited Process for preparing sulphonamides
WO2009091941A1 (en) * 2008-01-17 2009-07-23 Purdue Research Foundation Small molecule inhibitors of hiv proteases
EP2307345A4 (en) 2008-07-01 2012-05-02 Purdue Research Foundation NON-PEPTIDINHIBITORS OF HIV-1 PROTEASE
US8501961B2 (en) * 2008-07-09 2013-08-06 Purdue Research Foundation HIV protease inhibitors and methods for using
WO2010132494A1 (en) 2009-05-11 2010-11-18 Ghosh Arun K Compounds and methods for treating aids and hiv infections
WO2011061590A1 (en) 2009-11-17 2011-05-26 Hetero Research Foundation Novel carboxamide derivatives as hiv inhibitors
US9309213B2 (en) 2011-07-11 2016-04-12 Purdue Research Foundation C-3 substituted bicyclooctane based HIV protease inhibitors
CN104892478A (zh) * 2014-03-06 2015-09-09 上海爱启生态科技有限公司 一种治疗癌症的硒化白藜芦醇制剂
CN104892558A (zh) * 2014-03-06 2015-09-09 上海爱启生态科技有限公司 一种高硒含量硒化茶多酚制剂
US9738664B2 (en) * 2014-10-29 2017-08-22 Wisconsin Alumni Research Foundation Boronic acid inhibitors of HIV protease
WO2018023054A1 (en) * 2016-07-28 2018-02-01 Kansas State University Research Foundation Protease transition state inhibitor prodrugs
UY37592A (es) 2017-02-06 2018-08-31 Gilead Sciences Inc Compuestos inhibidores del vih
TWI829205B (zh) 2018-07-30 2024-01-11 美商基利科學股份有限公司 抗hiv化合物
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
US5475027A (en) * 1990-11-19 1995-12-12 G.D. Searle & Co. Retroviral protease inhibitors
WO1993008184A1 (en) * 1991-10-23 1993-04-29 Merck & Co., Inc. Hiv protease inhibitors
BR9306058A (pt) * 1992-03-11 1997-11-18 Narhex Ltd Derivados de amina de hidrocarbonetos oxo- e hidroxi- substituidos
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
DE122007000045I2 (de) * 1992-08-25 2011-07-21 Gd Searle Llc Gd Searle Llc Darunavir oder pharmazeutisch vertragliche Salze, Hydroxyethylaminosulfonamide verwendbar als InhibiEster oder Prodrugs davon. toren retroviraler Proteasen.
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
JPH06204323A (ja) * 1992-10-27 1994-07-22 Applied Materials Inc ウェハプロセスチャンバ内のドーム状加熱ペディスタルのためのクランプリング
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
US5514801A (en) 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
WO1994026749A1 (en) * 1993-05-14 1994-11-24 Merck & Co., Inc. Hiv protease inhibitors
JPH0789951A (ja) * 1993-06-03 1995-04-04 Sterling Winthrop Inc インターロイキン−1β転換酵素阻害剤
ES2127938T3 (es) 1993-08-24 1999-05-01 Searle & Co Hidroxietilamino sulfonamidas utiles como inhibidores de proteasas retroviricas.
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5728718A (en) * 1994-12-20 1998-03-17 The United States Of America As Represented By The Department Of Health And Human Services 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) * 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US5753660A (en) * 1995-11-15 1998-05-19 G. D. Searle & Co. Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
JPH11514996A (ja) 1995-11-21 1999-12-21 ノバルティス アクチエンゲゼルシャフト レトロウイルスアスパラギン酸プロテアーゼの置換同配体としてのアザヘキサン誘導体
WO1997046514A1 (en) * 1996-05-31 1997-12-11 Novartis Ag Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
BR9912169A (pt) 1998-06-19 2001-04-10 Vertex Pharma Inibidores de sulfonamida de protease de aspartil
AU4828199A (en) 1998-06-23 2000-01-10 Board Of Trustees Of The University Of Illinois, The Multi-drug resistant retroviral protease inhibitors and associated methods
US6319946B1 (en) * 1999-02-12 2001-11-20 Vertex Pharmaceuticals Incorporated Inhibitors of aspartyl protease
EP1159278B1 (en) * 1999-02-12 2005-11-30 Vertex Pharmaceuticals Incorporated Inhibitors of aspartyl protease
US6100227A (en) * 1999-04-17 2000-08-08 Joan Docter Industrial cleaner dispersant formulation
US6245806B1 (en) * 1999-08-03 2001-06-12 Merck & Co., Inc. HIV integrase inhibitors
CA2386850C (en) 1999-10-06 2010-03-30 Piet Tom Bert Paul Wigerinck Hexahydrofuro[2,3-b]furan-3-yl-n-{3-[(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl} carbamate as retroviral protease inhibitor
EP1370543B1 (en) 2001-02-14 2006-10-25 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
EP1397367A2 (en) 2001-04-09 2004-03-17 Tibotec Pharmaceuticals Ltd. Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
US7622490B2 (en) 2001-05-11 2009-11-24 Tibotec Pharmaceuticals, Ltd. Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
US7157489B2 (en) * 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors

Similar Documents

Publication Publication Date Title
EP2640720B1 (en) Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
ES2889926T3 (es) Tienopiridinas y benzotiofenos útiles como inhibidores de IRAK4
AU2017289038B2 (en) Immunomodulator compounds
ES2923682T3 (es) Derivado de amino-fluoropiperidina como inhibidor de cinasa
CA3146679A1 (en) Adenosine derivative and pharmaceutical composition comprising the same
AU2022210247C1 (en) Substituted pyridotriazine compounds and uses thereof
AU695032B2 (en) Purine and guanine compounds as inhibitors of PNP
TWI858267B (zh) 用於治療hiv之蛋白殼抑制劑
JP6860585B2 (ja) 非環状抗ウイルス 優先出願の参照による組み込み
CA3165889A1 (en) Pyridazinyl-thiazolecarboxamide compound
ES2908224T3 (es) Derivados de dolastatina 10 y auristatinas
EA019749B1 (ru) Противовирусные соединения
BRPI0720858B1 (pt) pirimidinas 6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
KR19980703203A (ko) 신규 펩티드 유도체
CA2775697A1 (en) Cyclic peptide inhibitors of hepatitis c virus replication
EA022118B1 (ru) Ингибиторы протеазы hcv
PT2069303E (pt) Inibidores de protease antiviral
US20190185508A1 (en) Deuterated nucleoside reverse transcriptase inhibitors
WO2020211672A1 (en) Cd73 inhibitors
EP1485387A1 (en) Carbamates as hiv protease inhibitors
EP1725102A1 (en) Hiv integrase inhibitors
WO2013162757A1 (en) Cytotoxic-drug delivering molecules targeting hiv (cdm-hs), cytotoxic activity against the human immunodeficiency virus and methods of use
TW201245144A (en) Novel compounds useful for the treatment of metabolic and inflammatory diseases
HUT74453A (en) 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkane-carboxylic acid derivatives, process for preparing them, their intermediates, use and pharmaceutical compns. contg. the said compds.
US8614339B2 (en) Dimeric derivatives of artemisinin and application in anti-cancer therapy